Dr. Schuehsler has dedicated his career to exploring new horizons as an investor, pursuing innovation and building teams and businesses, sometimes from scratch, sometimes in new regions, and always in healthcare – with an eye on products or services to address unmet medical needs and promote societal progress. During his tenure with the TVM Capital group, Dr. Schuehsler started biotech investing and made the firm the leading and largest life science investor in Germany and one of the leading pan-European investors. He also started the life science activities in the Boston office. Starting in 2007, he spearheaded the creation of TVM Capital Healthcare which was domiciled in Dubai in 2009 and expanded to Singapore in late 2018. Dr. Schuehsler has been the deal leader on more than 35 direct investments in life science and healthcare companies in Europe, the U.S., the Middle East, and India. In total, he has raised more than US$1bn from more than 50 international investors, has overseen more than 120 investments in the health market, and more than 50 IPOs and 30 M&A exit transactions in the portfolio. In 2007 and 2008, Dr. Schuehsler served as chairman of the European Private Equity and Venture Capital Association (EVCA, now “Invest Europe”). Currently, he is a director at the F-star Group of Companies (Boston, Vienna, and Cambridge, UK) and Vice-Chairman of the Board of Apeiron Biologics, Vienna.